Breaking News Instant updates and real-time market news.

MDT

Medtronic

$88.93 /

-0.31 (-0.35%)

08:09
04/08/19
04/08
08:09
04/08/19
08:09

Medtronic says study finds TDD associated with health care utilization reduction

Medtronic announced results of a study published in JAMA Network Open that demonstrates a reduction in health care utilization and cost for cancer pain patients using targeted drug delivery and conventional medical management vs. CMM alone. The study found significant cost savings to payors, with fewer inpatient visits, shorter inpatient length of stay, and fewer emergency department visits for the TDD and CMM group. Over 12 months, TDD therapy was associated with a significant mean overall cost savings of $63,498 and fewer oral opioid prescriptions per patient. TDD, delivered via the Medtronic SynchroMed II Infusion System, is an alternative to oral opioids for patients and provides effective pain relief at a fraction of the oral dose with fewer side effects and may help reduce the use of oral opioids. The paper reports the results of a retrospective propensity-score matched analysis conducted using a large U.S. claims database comparing mean total commercial payer costs and health care utilization at two, six, and 12 months. Researchers matched commercial insurance beneficiaries with patients with severe uncontrolled cancer pain receiving TDD and CMM or CMM alone. Participants were matched on age, sex, cancer type, comorbidity score, and pre-enrollment characteristics. After matching, each group included 268 patients. The study found that compared with CMM alone, TDD and CMM demonstrated the following per patient: Cost savings: a mean total cost savings of $15,142 at 2 months and $63,498 at 12 months; cost savings at 6 months was not statistically significant; Fewer inpatient visits at 2 months, 6 months, and 12 months; Shorter hospital stays at 2 months, 6 months, 12 months; An association with fewer prescriptions for oral opioids at 12 months The study showed that TDD and CMM is a cost-saving therapy to treat cancer pain, and based on these findings, increased use of TDD may have the potential to reduce future health care cost and utilization. As cancer rates continue increasing with the aging population, the authors concluded that considering more patients with significant cancer-related pain for TDD may result in substantial cost savings alongside improved quality of life. TDD is proven safe and effective for managing cancer pain in patients whose life expectancy is three months or more. A study showed that at four weeks, 60 percent of patients using TDD and CMM reported a pain score of less than four compared to 42 percent using CMM alone. Patients who received TDD and CMM also experienced fewer side effects, including less vomiting and confusion, fewer behavioral changes, and significantly less fatigue and sedation. Patients who received TDD in another study experienced improvements in function.

  • 18

    May

MDT Medtronic
$88.93 /

-0.31 (-0.35%)

03/29/19 Stifel
IntriCon added to Select List at Stifel
03/18/19 Wells Fargo
Edwards Lifesciences price target raised to $202 from $188 at Wells Fargo
03/18/19 Canaccord
Edwards Lifesciences price target raised to $215 from $190 at Canaccord
03/18/19 Piper Sandler
Piper sees minimal impact from FDA review of paclitaxel coated devices

TODAY'S FREE FLY STORIES

Hot Stocks
Cinemark raises annual dividend 6% to $1.44 per share » 06:18
02/21/20
02/21
06:18
02/21/20
06:18
CNK

Cinemark

$32.69 /

+0.58 (+1.81%)

The fourth quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cinemark reports Q4 EPS 22c, consensus 43c » 06:17
02/21/20
02/21
06:17
02/21/20
06:17
CNK

Cinemark

$32.69 /

+0.58 (+1.81%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Airbus plans to invest up to EUR1B in A220 program in 2020, Reuters says » 06:16
02/21/20
02/21
06:16
02/21/20
06:16
EADSY

Airbus

$0.00 /

+ (+0.00%)

, BDRBF

Bombardier

$0.00 /

+ (+0.00%)

Airbus expects to invest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Coca-Cola reaffirms full year guidance » 06:16
02/21/20
02/21
06:16
02/21/20
06:16
KO

Coca-Cola

$59.68 /

-0.1 (-0.17%)

The Coca-Cola Company is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Petrobras workers suspend strike and accept mediation, Reuters reports » 06:15
02/21/20
02/21
06:15
02/21/20
06:15
PBR

Petrobras

$14.40 /

-0.49 (-3.29%)

Workers on strike at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
E-Trade downgraded to Market Perform from Outperform at JMP Securities » 06:15
02/21/20
02/21
06:15
02/21/20
06:15
ETFC

E-Trade

$54.59 /

+9.65 (+21.47%)

, MS

Morgan Stanley

$53.73 /

-2.58 (-4.58%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Guardant Health initiated with a Buy at Guggenheim » 06:14
02/21/20
02/21
06:14
02/21/20
06:14
GH

Guardant Health

$87.30 /

+0.64 (+0.74%)

Guggenheim analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Fastly price target raised to $27 from $24 at Piper Sandler » 06:13
02/21/20
02/21
06:13
02/21/20
06:13
FSLY

Fastly

$24.59 /

+0.375 (+1.55%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Royal Bank of Canada raises quarterly dividend 3% to C$1.08 per share » 06:13
02/21/20
02/21
06:13
02/21/20
06:13
RY

Royal Bank of Canada

$81.41 /

-0.11 (-0.13%)

Payable on and after May…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Floor & Decor price target raised to $58 from $46 at Piper Sandler » 06:12
02/21/20
02/21
06:12
02/21/20
06:12
FND

Floor & Decor

$54.87 /

+1.37 (+2.56%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Avis Budget downgraded to Neutral from Buy at Northcoast » 06:11
02/21/20
02/21
06:11
02/21/20
06:11
CAR

Avis Budget

$50.41 /

+7.06 (+16.29%)

Northcoast downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
HMS Holdings sees FY20 CapEx approximately $30M-$35M » 06:10
02/21/20
02/21
06:10
02/21/20
06:10
HMSY

HMS Holdings

$27.47 /

-0.68 (-2.42%)

Sees FY20 effective tax…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
MercadoLibre to boost Mexico investment by 46%, Reuters says » 06:10
02/21/20
02/21
06:10
02/21/20
06:10
MELI

MercadoLibre

$742.88 /

+1.04 (+0.14%)

Daina Beth Solomon of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Crocs recent pullback a buying opportunity, says Piper Sandler » 06:10
02/21/20
02/21
06:10
02/21/20
06:10
CROX

Crocs

$36.95 /

-1.89 (-4.87%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Shake Shack downgraded to Hold from Buy at SunTrust » 06:10
02/21/20
02/21
06:10
02/21/20
06:10
SHAK

Shake Shack

$76.69 /

+0.615 (+0.81%)

SunTrust analyst Jake…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Wells Fargo prepares to settle over sales practices abuses, NY Times reports » 06:08
02/21/20
02/21
06:08
02/21/20
06:08
WFC

Wells Fargo

$47.34 /

+0.25 (+0.53%)

Wells Fargo is nearing a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Black Stone Minerals downgraded to Neutral from Overweight at Piper Sandler » 06:07
02/21/20
02/21
06:07
02/21/20
06:07
BSM

Black Stone Minerals

$10.35 /

+0.16 (+1.57%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Royal Bank of Canada CEO says 'we had a strong start to the year' » 06:07
02/21/20
02/21
06:07
02/21/20
06:07
RY

Royal Bank of Canada

$81.41 /

-0.11 (-0.13%)

Dave McKay, RBC President…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Royal Bank of Canada raises quarterly dividend 3% to C$1.08 per share  06:06
02/21/20
02/21
06:06
02/21/20
06:06
RY

Royal Bank of Canada

$81.41 /

-0.11 (-0.13%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Royal Bank of Canada reports Q1 diluted EPS C$2.40, up 12% y/y » 06:06
02/21/20
02/21
06:06
02/21/20
06:06
RY

Royal Bank of Canada

$81.41 /

-0.11 (-0.13%)

Reports Q1 ROE of 17.6%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Bernstein upgrades Sprouts Farmers Market to Outperform after selloff » 06:05
02/21/20
02/21
06:05
02/21/20
06:05
SFM

Sprouts Farmers Market

$16.05 /

+0.185 (+1.17%)

Bernstein analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Escalade reports Q4 EPS 18c vs. 25c last year » 06:04
02/21/20
02/21
06:04
02/21/20
06:04
ESCA

Escalade

$8.57 /

+0.03 (+0.35%)

Reports Q4 revenue $47M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
HMS Holdings sees FY20 revenue $705M-$715M, consensus $701.56M » 06:03
02/21/20
02/21
06:03
02/21/20
06:03
HMSY

HMS Holdings

$27.47 /

-0.68 (-2.42%)

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
L Brands upgraded to Outperform from In Line at Evercore ISI » 06:03
02/21/20
02/21
06:03
02/21/20
06:03
LB

L Brands

$23.43 /

-0.565 (-2.35%)

Evercore ISI analyst Omar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Square price target raised to $99 from $80 at Citi » 06:03
02/21/20
02/21
06:03
02/21/20
06:03
SQ

Square

$85.74 /

+0.48 (+0.56%)

Citi analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.